NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

心房纤维颤动 (AF) 治疗市场 - 市场规模,占有率,预测,机会分析:2020年~2027年

Atrial Fibrillation Market, By Procedure (Pharmacological, Non-Pharmacological ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品编码 959459
出版日期 内容资讯 英文 140 Pages
商品交期: 2-3个工作天内
价格
心房纤维颤动 (AF) 治疗市场 - 市场规模,占有率,预测,机会分析:2020年~2027年 Atrial Fibrillation Market, By Procedure (Pharmacological, Non-Pharmacological ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年09月01日内容资讯: 英文 140 Pages
简介

心房纤维颤动 (AF) ,是由于心脏电气系统的障碍引起的心律异常区别的心脏的心律不整的一种。在预测期间中,预计产品核可的增加,心房纤维颤动的高盛行率,促进市场成长。

本报告提供全球心房纤维颤动 (AF) 治疗市场相关调查分析,市场概要,市场规模与预测,各市场区隔的市场分析,各地区的市场分析,竞争情形等相关的系统性资讯。

目录

第1章 调查目的与前提条件

第2章 市场范围

第3章 市场动态、规定、趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 主要的焦点
  • 产品销售
  • PEST分析
  • 技术的进步
  • 法规方案
  • M&A

第4章 全球心房纤维颤动 (AF) 治疗市场:各治疗

  • 简介
  • 药理学性
  • 非药理学性

第5章 全球心房纤维颤动 (AF) 治疗市场:各地区

  • 简介
  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第6章 竞争情形

  • 企业简介
    • AtriCure, Inc.
    • Biosense Webster, Inc.
    • Boehringer Ingelheim GmbH
    • Boston Scientific Corporation
    • Bristol-Myers Squibb Corporation
    • CardioFocus, Inc.
    • Endoscopic Technologies, Inc.
    • Sanofi Aventis
    • Johnson and Johnson Ltd.
    • Abbott Laboratories

第7章 Section

目录

Title:
Atrial Fibrillation Market, By Procedure (Pharmacological (Anti-arrhythmic, Anti-coagulant), Non-Pharmacological (Catheter Ablation Procedures, Maze surgery, Electric Cardioversion)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & AFrica) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Atrial Fibrillation is also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. It is linked with an elevated risk of heart failure, stroke, and dementia. Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart's electrical system. High prevalence of atrial fibrillation along with increasing product approvals during the forecasted period is expected to assist the growth of the market. Furthermore, major players in the global atrial fibrillation market are focused on R&D to expand their product portfolio which is also expected to drive the market during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Atrial Fibrillation market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Atrial Fibrillation market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Inc., Johnson and Johnson Ltd., and Abbott Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Atrial Fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Atrial Fibrillation market

Detailed Segmentation:

  • Global Atrial Fibrillation Market, By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
  • Global Atrial Fibrillation Market, By Region:
  • North America
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion s
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • AtriCure, Inc. *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Biosense Webster, Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Corporation
  • CardioFocus, Inc.
  • Endoscopic Technologies, Inc.
  • Sanofi Aventis, Inc.
  • Johnson and Johnson Ltd.
  • Abbott Laboratories
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Procedure
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Atrial Fibrillation Market, By Procedure, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pharmacological
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Anti-arrhythmic
    • Anti-coagulant
  • Non-Pharmacological
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion

5. Global Atrial Fibrillation Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

  • Company Profiles
    • AtriCure, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Biosense Webster, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol-Myers Squibb Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CardioFocus, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Endoscopic Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi Aventis
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson and Johnson Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact